Journal of Cancer Research and Therapeutics Close
 

Figure 1: A 46-year-old female with Stage IV adenocarcinoma treated with camrelizumab and microwave ablation. (a-d) Multiple pulmonary metastases preablation. (e and f) Two lesions in the right lung were treated with microwave ablation. (g and h) Four months later, the lesions treated with microwave ablation became fibrotic scar. (i and j) Two months after administration of camrelizumab, the lesions disappeared and the response of immunotherapy was complete response

Figure 1: A 46-year-old female with Stage IV adenocarcinoma treated with camrelizumab and microwave ablation. (a-d) Multiple pulmonary metastases preablation. (e and f) Two lesions in the right lung were treated with microwave ablation. (g and h) Four months later, the lesions treated with microwave ablation became fibrotic scar. (i and j) Two months after administration of camrelizumab, the lesions disappeared and the response of immunotherapy was complete response